Hormonal therapy continues to be the procedure of initial option for metastatic people with endocrine-responsive breast cancer (LoE 1a A, AGO ++). The sequential use in the out there drugs will depend on the person pretreatment. Reassessment of ER, PR, and HER2 in tumor tissue at the time of https://rudyardm653uhq5.wikigop.com/user